# Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence

> **NCT01175941** · PHASE1 · COMPLETED · sponsor: **Norgine** · enrollment: 14 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DRUG:** NRL001
- **DRUG:** Placebo control

## Key facts

- **NCT ID:** NCT01175941
- **Lead sponsor:** Norgine
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2012-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175941, "Effect of 7 Days of Dosing With a 10 mg Rectal Suppository of NRL001in Patients With Faecal Incontinence". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01175941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*